We found that metformin significantly down-regulated N-cadherin, p65 and its downstream molecules (c-FLIP and FBXL10 [13]), accompanied by up-regulation of c-Fos in both prostate and bladder cancer cells (Fig. 3A). This evidence concerns the gene FOS and urinary bladder carcinoma.